Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CARDIOIMMUNOLOGY

Fibroblasts tune myocardial inflammation and remodeling

The replacement of damaged cardiomyocytes by extracellular matrix-producing fibroblasts underpins adverse remodeling in the failing heart. New research finds that MHC class II-dependent fibroblast–CD4+ T cell interactions in the myocardium lead to fibroblast activation and exacerbate fibrotic remodeling of the myocardium.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Local antigen presentation by cardiac fibroblasts affects cardiac function.

References

  1. Janeway, C. A. Cold Spring Harb. Symp. Quant. Biol. 54, 1–13 (1989).

    Article  CAS  Google Scholar 

  2. Burnet, F. M. Aust. J. Sci. 20, 67–69 (1957).

    Google Scholar 

  3. Bretscher, P. & Cohn, M. Science 169, 1042–1049 (1970).

    Article  CAS  Google Scholar 

  4. Schwartz, R. H. Science 248, 1349–1356 (1990).

    Article  CAS  Google Scholar 

  5. Grossman, Z. & Paul, W. E. Semin. Immunol. 12, 197–203 (2000).

    Article  CAS  Google Scholar 

  6. Ngwenyama, N. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-022-00116-7 (2022).

    Article  Google Scholar 

  7. Souders, C. A., Borg, T. K., Banerjee, I. & Baudino, T. A. Am. J. Pathol. 181, 1226–1235 (2012).

    Article  Google Scholar 

  8. Simons, K. H. et al. Nat. Rev. Cardiol. 16, 325–343 (2019).

    Article  Google Scholar 

  9. Krovi, S. H. & Kuchroo, V. K. Immunol. Rev. 307, 161–190 (2022).

    Article  CAS  Google Scholar 

  10. Nevers, T. et al. J. Exp. Med. 214, 3311–3329 (2017).

    Article  CAS  Google Scholar 

  11. Gomes, J. A. et al. Infect. Immun. 71, 1185–1193 (2003).

    Article  CAS  Google Scholar 

  12. Teiger, E. et al. J. Clin. Invest. 97, 2891–2897 (1996).

    Article  CAS  Google Scholar 

  13. Lv, H. et al. J. Clin. Invest. 121, 1561–1573 (2011).

    Article  CAS  Google Scholar 

  14. Gil-Cruz, C. et al. Science 366, 881–886 (2019).

    Article  CAS  Google Scholar 

  15. Rieckmann, M. et al. J. Clin. Invest. 130, 4922–4936 (2019).

    Article  Google Scholar 

Download references

Acknowledgements

We thank N. Pikor for critical reading of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Burkhard Ludewig.

Ethics declarations

Competing interests

C.G.C., C.P.S. and B.L. are co-founders and shareholders of Stromal Therapeutics.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perez-Shibayama, C., Gil-Cruz, C. & Ludewig, B. Fibroblasts tune myocardial inflammation and remodeling. Nat Cardiovasc Res 1, 694–695 (2022). https://doi.org/10.1038/s44161-022-00119-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-022-00119-4

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing